Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media arrow down
      < Back
    • Media
    • Press Release
  • Investors
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Our Culture
  • Press shift tab to select search category

    Loading...
  • Global Australia
    < Back
    • Global
    • Annual Report
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Companyarrow down
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Foundation Ipsen
  • Sciencearrow down
      < Back
    • Science
    • Therapeutic Areas
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
  • Responsibilityarrow down
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • Patients
    • People
    • Governance
  • Patients
  1. Home
  2. Company
  3. Leadership
  4. Simon Higgins

Simon Higgins

Back
Simon Higgins

Simon Higgins

  • Market Access and Public Affairs Director
  • Follow in LinkedIn

Simon leads the Ipsen ANZ Market Access and Public Affairs function, with a primary focus on enabling patient access to Ipsen’s portfolio of medicines through reimbursement.

Simon has a broad background of over 20 years in the Australian and New Zealand pharmaceutical industry across market access, public affairs and commercial excellence roles, and holds a Master of Business Administration, and Master of Public Health from the University of Melbourne.

​

IPN price

€102.70

 €-1.00 (-0.96%)

  • Media
  • Investors
  • Careers
  • Annual Report
  • Contact us
  • Distribution

Latest_Ipsen logo
LinkedIn Facebook Instagram Youtube
  • Terms and conditions
  • Cookie Policy
  • Privacy Policy

© Ipsen Pharma. All rights reserved - 2025 Date of preparation: April 2024 CRSC-AU-000016

You are now leaving the Ipsen Australia website. To continue, please click on Continue?

Continue